# Integration of metabolomics and transcriptomics to reveal metabolic characteristics and the role of mTORC1 in β-cell proliferation induced by a short-term high-fat diet

**Authors:** Jiajia Wang, Jing Li, Yunshan Li, Mengran Liu, Shan Huang, Wenyi Li

PMC · DOI: 10.7717/peerj.20871 · 2026-02-23

## TL;DR

This study shows that a short-term high-fat diet promotes pancreatic β-cell growth through the mTORC1 pathway, which can be blocked by rapamycin.

## Contribution

The study identifies mTORC1 as a key driver of β-cell proliferation in response to a high-fat diet.

## Key findings

- A short-term high-fat diet increases pancreatic β-cell proliferation without affecting insulin sensitivity.
- The mTORC1 signaling pathway is crucial for diet-induced β-cell proliferation.
- Rapamycin inhibits β-cell proliferation caused by the high-fat diet.

## Abstract

Pancreatic β-cell proliferation is essential for maintaining the balance of β-cell mass, and an elevated metabolic load can stimulate their proliferation. Numerous studies have shown that a short-term high-fat diet increases metabolic load without affecting insulin sensitivity, thereby promoting the proliferation of pancreatic β-cells. However, the underlying mechanisms of this effect remain to be fully elucidated.

A model has been constructed in our study to emulate pancreatic β-cell proliferation induced by a short-term high-fat diet, aiming to scrutinize the underlying mechanisms. Integrated transcriptomic and metabolomic analyses suggest that the mTORC1 signaling pathway may be crucial in this induced proliferation. Further analysis revealed that rapamycin, a specific inhibitor of the mTORC1 pathway, can inhibit proliferation induced by the short-term high-fat diet.

Our study confirms the significant role of the mTORC1 signaling pathway in pancreatic β-cell proliferation induced by a short-term high-fat diet.

## Linked entities

- **Proteins:** Crtc (CREB-regulated transcription coactivator)
- **Chemicals:** rapamycin (PubChem CID 5284616)

## Full-text entities

- **Genes:** Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Hars1 (histidyl-tRNA synthetase 1) [NCBI Gene 15115] {aka Hars, MMHRS}, Cdk4 (cyclin dependent kinase 4) [NCBI Gene 12567] {aka Crk3}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Card11 (caspase recruitment domain family, member 11) [NCBI Gene 108723] {aka 0610008L17Rik, 2410011D02Rik, BIMP3, CARMA1}, Rps6 (ribosomal protein S6) [NCBI Gene 20104] {aka S6R}, Mafa (MAF bZIP transcription factor A) [NCBI Gene 378435] {aka RIPE3b1}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Rps6kb1 (ribosomal protein S6 kinase B1) [NCBI Gene 72508] {aka 2610318I15Rik, P70S6K1, S6K, S6K-beta-1, S6K1, p70 S6K-alpha}, Eif4b (eukaryotic translation initiation factor 4B) [NCBI Gene 75705] {aka 2310046H11Rik, Eif4a2}, S1pr1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 13609] {aka Edg1, Lpb1, S1p, S1p1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Rab31 (RAB31, member RAS oncogene family) [NCBI Gene 106572] {aka 1700093E07Rik, Rab22B}, Ccnd1 (cyclin D1) [NCBI Gene 12443] {aka CycD1, Cyl-1, PRAD1, bcl-1, cD1}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Cdk2 (cyclin dependent kinase 2) [NCBI Gene 12566] {aka A630093N05Rik}, Bmp6 (bone morphogenetic protein 6) [NCBI Gene 12161] {aka D13Wsu115e, Vgr1}, Slc2a2 (solute carrier family 2 (facilitated glucose transporter), member 2) [NCBI Gene 20526] {aka Glut-2, Glut2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Tfeb (transcription factor EB) [NCBI Gene 21425] {aka Tcfeb, bHLHe35}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Eif4ebp1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 13685] {aka 4e-bp1, PHAS-I}, Irs2 (insulin receptor substrate 2) [NCBI Gene 384783] {aka Irs-2}, Ccnd2 (cyclin D2) [NCBI Gene 12444] {aka 2600016F06Rik, Vin-1, Vin1, cD2}, Arhgdib (Rho, GDP dissociation inhibitor beta) [NCBI Gene 11857] {aka D4, Gdid4, Ly-GDI}, Plbd1 (phospholipase B domain containing 1) [NCBI Gene 66857] {aka 1100001H23Rik, LyLAP}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Rptor (regulatory associated protein of MTOR, complex 1) [NCBI Gene 74370] {aka 4932417H02Rik, Rap, Raptor, mKIAA1303}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Tsc2 (TSC complex subunit 2) [NCBI Gene 22084] {aka Nafld, Tcs2}, Tsc1 (TSC complex subunit 1) [NCBI Gene 64930], Rheb (Ras homolog enriched in brain) [NCBI Gene 19744] {aka Rheb1}, Mapk9 (mitogen-activated protein kinase 9) [NCBI Gene 26420] {aka JNK2, Prkm9, p54aSAPK}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Gck (glucokinase) [NCBI Gene 103988] {aka GLK, Gk, Gls006, HK4, HKIV, HXKP}
- **Diseases:** obesity (MESH:D009765), cervical dislocation (MESH:D002575), disease (MESH:D004194), Diabetes (MESH:D003920), cancer (MESH:D009369), insufficient insulin (MESH:D000309), unconscious (MESH:D014474), impairment of pancreatic beta (MESH:D010195), breast cancer (MESH:D001943), T2D (MESH:D003924), hyperplasia (MESH:D006965), dislocation (MESH:D004204), impaired glucose intolerance (MESH:D018149), hepatocellular carcinoma (MESH:D006528), cell (MESH:D002292), rheumatoid arthritis (MESH:D001172), hypertrophy (MESH:D006984), insulin resistance (MESH:D007333), lethargy (MESH:D053609), weight loss (MESH:D015431), toxicity (MESH:D064420)
- **Chemicals:** Sphingosine-1-phosphate (MESH:C060506), phospholipid (MESH:D010743), water (MESH:D014867), Trizol (MESH:C411644), free fatty acids (MESH:D005230), SDS (MESH:D012967), hydrochloric acid (MESH:D006851), PEG400 (MESH:C000595213), Blood glucose (MESH:D001786), ethanol (MESH:D000431), poly-T (MESH:D011071), methanol (MESH:D000432), fat (MESH:D005223), paraffin (MESH:D010232), ammonium formate (MESH:C030544), Rapamycin (MESH:D020123), sodium pentobarbital (MESH:D010424), acetonitrile (MESH:C032159), agarose (MESH:D012685), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), polyvinylidene fluoride (MESH:C024865), alcohol (MESH:D000438), sphingolipid (MESH:D013107), oleate (MESH:D019301), Tween 80 (MESH:D011136), PBS (MESH:D007854), poly-A (MESH:D011061), calcium (MESH:D002118), Glucose (MESH:D005947), palmitate (MESH:D010168), H&amp;E (MESH:D006371), 2-chlorobenzalanine (-), amino acids (MESH:D000596), monounsaturated fatty acids (MESH:D005229), fatty acid (MESH:D005227), CDCA (MESH:D002635)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Cavia porcellus (domestic guinea pig, species) [taxon 10141], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81)

## Figures

18 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939796/full.md

---
Source: https://tomesphere.com/paper/PMC12939796